Mikkonen P. et al. 2019
"The systematic successful treatment of cancer still eludes us and in an effort to refine this area of targeted medicine, Lauri Paasonen and colleagues explore the potential of using patient-derived cells (PDCs) for devising a personalised treatment strategy for solid tumours."
Mikkonen P. et al. Next generation sequencing for cancer precision medicine. Drug Target Review 2019, 3, 8-11.
We use cookies on this website to ensure the best user experience and target personalised content and relevant advertising. Some cookies are necessary to provide you with a trustworthy service and cannot be declined. Choose the best option for you.
For more information, please see our Privacy Policy.
Your selection
You control your data. We and our business partners use cookies to collect information about you for various purposes:
You may withdraw your consent at any time by clicking the Cookie settings in the footer of each page.
Your selection
You control your data. We and our business partners use cookies to collect information about you for various purposes:
You may withdraw your consent at any time by clicking the Cookie settings in the footer of each page.
UPM Biomedicals
Alvar Aallon katu 1
P.O. Box 380
00101 Helsinki, Finland
Tel. +358 (0)204 15 111
Fax +358 (0)204 15 110